Real-time enrollment status for this systemic lupus erythematosus (with and without nephritis) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:03 PM UTC
| NCT Number | NCT07085104 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus (With and Without Nephritis) |
| Phase | PHASE1 |
| Target Enrollment | 66 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Allogene Therapeutics |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 12, 2026: Clinical trial NCT07085104 is currently recruiting participants. This phase1 study for systemic lupus erythematosus (with and without nephritis) is actively seeking new participants at 16 locations across the United States. The study is sponsored by Allogene Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07085104 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07085104 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.